Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Alnylam Pharmace. | 49 | 0 | 5 | 0 | 249,10 € | 271,69 € | 9,07 % |
| Neurocrine Bioscience | 40 | 0 | 10 | 0 | 140,30 € | 149,47 € | 6,54 % |
| Jazz Pharmaceuticals plc | 32 | 0 | 6 | 0 | 103,85 € | 184,53 € | 77,69 % |
| Acadia Pharmaceuticals | 29 | 1 | 2 | 0 | 17,20 € | 31,78 € | 84,85 % |
| Icon plc | 24 | 0 | 3 | 0 | 290,80 € | 326,21 € | 12,18 % |
| Ultragenyx Pharmaceutical Inc. | 25 | 1 | 4 | 0 | 41,20 € | 86,28 € | 109,42 % |
| United Therapeutics | 24 | 1 | 5 | 1 | 300,30 € | 298,84 € | -0,49 % |
| Ionis Pharmaceuticals Inc. | 28 | 6 | 8 | 1 | 45,02 € | 56,72 € | 25,99 % |
| Merit Medical Systems | 22 | 0 | 2 | 0 | 78,00 € | 88,37 € | 13,29 % |
| Halozyme Therapeutics Inc. | 21 | 0 | 1 | 0 | 49,56 € | 53,53 € | 8,00 % |
| Exelixis Inc. | 20 | 0 | 3 | 0 | 22,13 € | 26,01 € | 17,52 % |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 4 | 0 | 24,01 € | 54,98 € | 128,99 % |
| Insulet Corp. | 17 | 0 | 0 | 0 | 180,05 € | 216,46 € | 20,22 % |
| Medpace Holdings Inc | 16 | 0 | 5 | 0 | 345,50 € | 418,12 € | 21,02 % |
| Alkermes plc | 17 | 2 | 3 | 0 | 25,00 € | 35,01 € | 40,05 % |
| Repligen Corp. | 15 | 0 | 4 | 0 | 148,20 € | 178,01 € | 20,12 % |
| Xencor Inc. | 15 | 1 | 1 | 0 | 18,20 € | 31,65 € | 73,92 % |
| Amedisys Inc. | 13 | 0 | 0 | 0 | 89,00 € | 92,26 € | 3,66 % |
| CONMED Corp. | 14 | 2 | 4 | 1 | 61,50 € | 98,42 € | 60,03 % |
| QIAGEN NV | 12 | 0 | 1 | 0 | 40,47 € | 47,52 € | 17,42 % |
| LivaNova plc | 12 | 0 | 2 | 0 | 45,00 € | 66,49 € | 47,76 % |
| Ensign Group Inc. | 10 | 0 | 0 | 0 | 128,00 € | 124,39 € | -2,82 % |
| Bio-Techne Corp. | 10 | 0 | 0 | 0 | 76,00 € | 75,94 € | -0,08 % |
| Agios Pharmaceuticals Inc. | 9 | 1 | 1 | 0 | 40,40 € | 48,75 € | 20,67 % |